IE
WHWK

Israel Englander’s Whitehawk Therapeutics WHWK Stock Holding History

Israel Englander’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.74M Buy
380,406
+70,732
+23% +$294K ﹤0.01% 3922
2026
Q1 		$1.07M Buy
+309,674
New +$969K ﹤0.01% 4345
2025
Q2 		– Sell
-44,823
Closed -$79.8K – 6472
2025
Q1 		$79.8K Sell
44,823
-129,175
-74% -$337K ﹤0.01% 5469
2024
Q4 		$549K Sell
173,998
-2,785
-2% -$6.31K ﹤0.01% 4675
2024
Q3 		$364K Sell
176,783
-49,302
-22% -$79.7K ﹤0.01% 5072
2024
Q2 		$330K Buy
+226,085
New +$419K ﹤0.01% 4854
2023
Q2 		– Sell
-72,375
Closed -$524K – 6802
2023
Q1 		$524K Sell
72,375
-2,214
-3% -$23.7K ﹤0.01% 4578
2022
Q4 		$957K Sell
74,589
-83,027
-53% -$1.08M ﹤0.01% 4211
2022
Q3 		$2.23M Buy
157,616
+127,652
+426% +$1.68M ﹤0.01% 3645
2022
Q2 		$369K Sell
29,964
-170,936
-85% -$2.54M ﹤0.01% 5192
2022
Q1 		$3.41M Buy
+200,900
New +$3.85M ﹤0.01% 3367
2021
Q4 		– Sell
-28,343
Closed -$832K – 7482
2021
Q3 		$832K Buy
28,343
+23,409
+474% +$713K ﹤0.01% 4875
2021
Q2 		$125K Buy
+4,934
New +$113K ﹤0.01% 6177
2020
Q4 		– Sell
-3,972
Closed -$89 – 5660
2020
Q3 		$89 Buy
+3,972
New +$83.6K ﹤0.01% 4242
2018
Q3 		– Sell
-15,000
Closed -$934K – 4341
2018
Q2 		$934K Buy
+15,000
New +$907K ﹤0.01% 2881

Other funds holding WHWK

YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $136M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Israel Englander's WHWK Position: Q2 2026 in Review

Israel Englander increased its Whitehawk Therapeutics (WHWK) stake by 23% in Q2 2026, buying an estimated $294K and bringing the position to 380,406 shares worth $1.74M. The position accounts for ﹤0.01% of the portfolio, ranked #3922.

Israel Englander first reported a position in WHWK in Q2 2018 and has held it in 15 quarters since. The position peaked at $3.41M in Q1 2022. 78 funds tracked by Wall St. Rank hold WHWK as of Q2 2026.

  • Israel Englander held 380,406 shares of Whitehawk Therapeutics worth $1.74M as of Q2 2026.
  • Israel Englander bought 70,732 Whitehawk Therapeutics shares in Q2 2026, an estimated $294K.
  • Whitehawk Therapeutics made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #3922 holding.
  • Israel Englander first reported a position in Whitehawk Therapeutics in Q2 2018 and has held it in 15 quarters since.
  • Israel Englander's Whitehawk Therapeutics position peaked at $3.41M in Q1 2022.
  • 78 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.